Genesis Research
Edward Ingham is an accomplished professional in the pharmaceutical and biotech industries, currently serving as the Founder of BioPharm BD since September 2023, providing strategic business development consulting. Ingham holds positions as a Board Member at Nutrartis, addressing unmet clinical needs in cardiovascular diseases, and Senior Director of Global Business Development at Genesis Research Group, overseeing the Rapid Payer Response™ platform. Previous experience includes roles as a Business Development Manager at Pharma Intelligence and Commercial Manager at Amaris, where responsibilities encompassed market access and business development for top pharmaceutical accounts. Ingham's educational background includes a Bachelor's Degree in International Business with French and Spanish from Sheffield Hallam University and studies at ESSEC Business School.
This person is not in any teams
This person is not in any offices
Genesis Research
1 followers
Genesis Research is an international healthcare organization providing consultancy services to the pharmaceutical and biotech industries.